OBJECTIVE: Regenerating islet-derived family, member 4 (regenerating gene type IV, Reg IV) is overexpressed in colorectal cancer (CRC). The aim of this study was to investigate the diagnostic utility of Reg IV determination in sera from patients with CRC. METHODS: We examined the expression and distribution of Reg IV in CRC by immunohistochemistry and determined Reg IV levels in sera from patients with CRC by enzyme-linked immunosorbent assay. RESULTS: Immunostaining revealed that 23 of 80 (29%) CRC cases were positive for Reg IV. CRC cases with metastatic recurrence in the liver showed more frequently Reg IV staining than those without (p = 0.0102). Patients with CRC showing Reg IV staining had a significantly worse survival than those without Reg IV staining (p = 0.0117). Preoperatively, serum Reg IV concentrations were not elevated in CRC patients at stage 0-III, being in contrast to the significantly increased preoperative levels in stage IV CRC patients with liver metastasis. CONCLUSION: These results suggest that Reg IV is a prognosticator for poor survival. Serum Reg IV concentration may predict CRC recurrence in the liver. (c) 2008 S. Karger AG, Basel
OBJECTIVE: Regenerating islet-derived family, member 4 (regenerating gene type IV, Reg IV) is overexpressed in colorectal cancer (CRC). The aim of this study was to investigate the diagnostic utility of Reg IV determination in sera from patients with CRC. METHODS: We examined the expression and distribution of Reg IV in CRC by immunohistochemistry and determined Reg IV levels in sera from patients with CRC by enzyme-linked immunosorbent assay. RESULTS: Immunostaining revealed that 23 of 80 (29%) CRC cases were positive for Reg IV. CRC cases with metastatic recurrence in the liver showed more frequently Reg IV staining than those without (p = 0.0102). Patients with CRC showing Reg IV staining had a significantly worse survival than those without Reg IV staining (p = 0.0117). Preoperatively, serum Reg IV concentrations were not elevated in CRC patients at stage 0-III, being in contrast to the significantly increased preoperative levels in stage IV CRC patients with liver metastasis. CONCLUSION: These results suggest that Reg IV is a prognosticator for poor survival. Serum Reg IV concentration may predict CRC recurrence in the liver. (c) 2008 S. Karger AG, Basel
Authors: Anuli Uzozie; Paolo Nanni; Teresa Staiano; Jonas Grossmann; Simon Barkow-Oesterreicher; Jerry W Shay; Amit Tiwari; Federico Buffoli; Endre Laczko; Giancarlo Marra Journal: Mol Cell Proteomics Date: 2014-02-24 Impact factor: 5.911
Authors: Kumar S Bishnupuri; Qizhi Luo; Satheesh K Sainathan; Kento Kikuchi; Sripathi M Sureban; Mekala Sabarinathan; Jennifer H Gross; Konrad Aden; Randal May; Courtney W Houchen; Shrikant Anant; Brian K Dieckgraefe Journal: Gastroenterology Date: 2009-11-10 Impact factor: 22.682
Authors: José María Sayagués; Celia Fontanillo; María del Mar Abad; María González-González; María Eugenia Sarasquete; Maria del Carmen Chillon; Eva Garcia; Oscar Bengoechea; Emilio Fonseca; Marcos Gonzalez-Diaz; Javier De las Rivas; Luís Muñoz-Bellvis; Alberto Orfao Journal: PLoS One Date: 2010-10-29 Impact factor: 3.240
Authors: Nobuo Sasaki; Norman Sachs; Kay Wiebrands; Saskia I J Ellenbroek; Arianna Fumagalli; Anna Lyubimova; Harry Begthel; Maaike van den Born; Johan H van Es; Wouter R Karthaus; Vivian S W Li; Carmen López-Iglesias; Peter J Peters; Jacco van Rheenen; Alexander van Oudenaarden; Hans Clevers Journal: Proc Natl Acad Sci U S A Date: 2016-08-29 Impact factor: 11.205